Current portfolio

Eloxx Pharma

Developing Therapeutics to treat genetic diseases

  • Sector
    Healthcare
  • Country
    United States/Israel
  • Fund
    LSP 5
  • Entry
    2017
  • Web
Logo

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
A purpose-driven global investment organization
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180